Akos Czibere
Förmögenhet: - $ per 2026-08-31
Förmögenhet: - $ per 2026-08-31
Akos Czibere currently works at Aktis Oncology, Inc., as Chief Medical Officer from 2024.
Dr. Czibere also formerly worked at Merrimack Pharmaceuticals, Inc., as Vice President-Clinical Development and Pfizer Inc., as Vice President-Therapeutic Area.
Dr. Czibere received his doctorate degree from Heinrich-Heine-Universität Düsseldorf.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
AKTIS ONCOLOGY, INC. -.--% | 2026-09-23 | 0 ( -.--% ) | - $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| AKTIS ONCOLOGY, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-07-01 |
| Företag | Position | Slut |
|---|---|---|
| PFIZER INC. | Företagsledare/Principal | - |
| MERRIMACK PHARMACEUTICALS | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Merrimack Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Heinrich-Heine-Universität Düsseldorf
Heinrich-Heine-Universität Düsseldorf Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aktis Oncology, Inc.
Aktis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers radiopharmaceuticals to treat tumor cancers | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån